Rankings
▼
Calendar
CMMB Q2 2024 Earnings — Chemomab Therapeutics Ltd. Revenue & Financial Results | Market Cap Arena
CMMB
Chemomab Therapeutics Ltd.
$12M
Q2 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$26,901
Operating Income
-$4M
Net Income
-$4M
EPS (Diluted)
$-1.01
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
$0
Free Cash Flow
$0
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$15M
Total Liabilities
$5M
Stockholders' Equity
$10M
Cash & Equivalents
$5M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$26,901
-$15,818
-70.1%
Operating Income
-$4M
-$8M
+54.0%
Net Income
-$4M
-$8M
+54.4%
← FY 2024
All Quarters
Q3 2024 →